The Delaware-based firm’s website gives no indication of who's behind the firm, which was incorporated in February, according to a Delaware state records search.
Advocates for rescheduling psychedelics like psilocybin, the hallucinogen found in magic mushrooms, to allow for investments in research of the drug, are finding some powerful allies for the cause.